Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
5.76
-0.25 (-4.16%)
At close: May 13, 2025, 4:00 PM
5.76
0.00 (0.00%)
Pre-market: May 14, 2025, 5:44 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Treatments for Various Diseases and Disorders, and Vaccines
20.00K
Log In
Log In
Log In
Log In
Upgrade
Treatments for Various Diseases and Disorders, and Vaccines Growth
-95.31%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
20.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-95.31%
Log In
Log In
Log In
Log In
Upgrade